Ketamine and Postoperative Depressive Symptom-PASSION

Brief Summary

Perioperative depression symptom (PDS) is one of the common mental comorbidity, and influences the clinical outcomes and prognosis. However, there is no rapid acting treatment to deal with it during the limited hospital stay. This study aims to determine whether ketamine could improve the depressive symptom of peirioperative patients. It will also examine the safety for administrating ketamine as an antidepressant intraoperatively. Meanwhile, it will show if ketamine could improve anxiety, postoperative pain or delirium. This trial also will bring great concerns on patients with perioperative mental health and explore the measures to improve their psycho-related prognosis.

Intervention / Treatment

  • Drug: Ketamine
  • Drug: Normal saline

Condition or Disease

  • Ketamine; Depressive Symptom; Neurosurgery; Perioperative Period

Phase

Study Design

Study type: Interventional
Status: Completed
Study results: No Results Available
Age: 18 Years to 65 Years   (Adult, Older Adult)
Enrollment: 84 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Jul 05, 2017
Primary Completion: Aug 24, 2018
Completion Date: Nov 20, 2018
Study First Posted: Mar 22, 2017
Results First Posted: Aug 31, 2020
Last Updated: Jul 07, 2020

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Location

Eligibility Criteria

Sex: All
Minimum Age: 18
Maximum Age: 65

More Details

NCT Number: NCT03086148
Other IDs: 3/16/17
Study URL: https://ClinicalTrials.gov/show/NCT03086148
Last updated: Jun 17, 2022